NEW YORK--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq:DCTH) today announced that its Chief Executive Officer, Richard L. Taney, will make a presentation titled, “Isolated High Dose Drug Delivery for the Treatment of Cancer and Hepatitis,” at the 12th Annual Drug Delivery Technologies and Deal Making Conference. The Delcath presentation is scheduled for 11:00 AM Eastern Time on Tuesday, September 25, 2007. The event will be held at the Hyatt Regency New Brunswick in New Brunswick, New Jersey from September 24 – 26, 2007.
